UCL researchers distinguish new immunotherapy to battle hepatitis B infection Kumar Jeetendra | May 15, 2021 Researchers at UCL have identified a new immunotherapy to fight the hepatitis B virus (HBV), the most frequent cause of liver cancer in the world. The pioneering study used immune cells isolated directly from patient liver and tumour tissue, to demonstrate that targeting acyl-CoA:cholesterol acyltransferase (ACAT), an enzyme which helps to manage cholesterol levels in …
Scientists create stable cell lines equipped for delivering different hepatitis B virus genotypes Kumar Jeetendra | February 15, 2022 A new study has created cells that can be stable and capable to produce different strains of the Hepatitis B virus (HBV) which is helping to improve understanding of the distinctive virological characteristics treatments, virological features, and infectivity, which could lead to the development of new treatments against the virus that infects humans as long …
